Arkolith/Insider Trading/RCUS/Form 4

Kaneko Yasunori

DirectorArcus Biosciences, Inc. (RCUS) · full profile →Form 4 · filed Feb 27, 2025
Net Buying
Open-Market Buys
$201K
Open-Market Sells
$0
Net Open-Market Flow
$201K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 27, 2025Buy(P)20K$10.06$201K28K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001724521-25-000046) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML